Pacific Biosciences of California (PACB) 8-K Results of Operations and Financial Condition

Exhibit 99.2

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Condensed Consolidated Statements of Operations and Comprehensive Loss

(Unaudited)

	Three-Month Periods Ended
(in thousands, except per share amounts)	March 31, 2013			March 31, 2012
Revenue:
Product revenue	$	3,833		$	8,715
Service and other revenue		1,475			1,053
Grant revenue		270			270
Total revenue		5,578			10,038
Cost of Revenue:
Cost of product revenue		3,200			8,607
Cost of service and other revenue		1,448			1,583
Total cost of revenue		4,648			10,190
Gross profit (loss)		930			(152	)
Operating Expense:
Research and development		11,983			12,073
Sales, general and administrative		9,554			15,285
Total operating expense		21,537			27,358
Operating loss		(20,607	)		(27,510	)
Other income (expense), net		(497	)		(70	)
Net loss	$	(21,104	)	$	(27,580	)
Other comprehensive income (loss):
Unrealized gain (loss) on investments		(19	)		78
Comprehensive loss	$	(21,123	)	$	(27,502	)
Net loss per share:
Basic and diluted net loss per share	$	(0.37	)	$	(0.50	)
Shares used in computing basic and diluted net loss per share		57,372			55,201